| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |